Morgan Stanley’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.45M Sell
48,204
-17,018
-26% -$512K ﹤0.01% 4907
2025
Q1
$1.86M Sell
65,222
-32,058
-33% -$914K ﹤0.01% 4652
2024
Q4
$3.21M Buy
97,280
+8,430
+9% +$278K ﹤0.01% 4346
2024
Q3
$3.32M Buy
88,850
+4,061
+5% +$152K ﹤0.01% 4285
2024
Q2
$2.85M Sell
84,789
-26,306
-24% -$883K ﹤0.01% 4325
2024
Q1
$3.97M Sell
111,095
-60,133
-35% -$2.15M ﹤0.01% 4099
2023
Q4
$5.64M Buy
171,228
+49,371
+41% +$1.63M ﹤0.01% 4304
2023
Q3
$3.32M Sell
121,857
-21,037
-15% -$573K ﹤0.01% 4032
2023
Q2
$4.51M Buy
142,894
+28,741
+25% +$907K ﹤0.01% 3853
2023
Q1
$3.1M Sell
114,153
-21,033
-16% -$572K ﹤0.01% 4159
2022
Q4
$4.11M Sell
135,186
-8,667
-6% -$263K ﹤0.01% 3925
2022
Q3
$4.33M Sell
143,853
-11,460
-7% -$345K ﹤0.01% 3811
2022
Q2
$4.3M Sell
155,313
-21,025
-12% -$582K ﹤0.01% 3896
2022
Q1
$5.93M Sell
176,338
-57,124
-24% -$1.92M ﹤0.01% 3494
2021
Q4
$9.86M Sell
233,462
-5,021
-2% -$212K ﹤0.01% 2968
2021
Q3
$10.9M Buy
238,483
+6,021
+3% +$274K ﹤0.01% 2792
2021
Q2
$11.4M Buy
232,462
+13,441
+6% +$658K ﹤0.01% 2836
2021
Q1
$11M Buy
219,021
+10,835
+5% +$545K ﹤0.01% 2549
2020
Q4
$10.7M Buy
208,186
+4,927
+2% +$252K ﹤0.01% 2449
2020
Q3
$8.36M Sell
203,259
-25,326
-11% -$1.04M ﹤0.01% 2193
2020
Q2
$9.56M Buy
228,585
+15,819
+7% +$662K ﹤0.01% 2011
2020
Q1
$6.75M Buy
212,766
+45,794
+27% +$1.45M ﹤0.01% 2162
2019
Q4
$7.06M Buy
166,972
+11,789
+8% +$498K ﹤0.01% 2810
2019
Q3
$4.9M Sell
155,183
-81,097
-34% -$2.56M ﹤0.01% 2899
2019
Q2
$8.53M Buy
236,280
+10,506
+5% +$379K ﹤0.01% 2336
2019
Q1
$8.17M Buy
225,774
+41,159
+22% +$1.49M ﹤0.01% 2238
2018
Q4
$5.2M Sell
184,615
-89,605
-33% -$2.52M ﹤0.01% 2867
2018
Q3
$10.8M Buy
274,220
+120,161
+78% +$4.73M ﹤0.01% 2332
2018
Q2
$5.74M Buy
154,059
+33,324
+28% +$1.24M ﹤0.01% 2988
2018
Q1
$4.13M Buy
120,735
+48,617
+67% +$1.66M ﹤0.01% 3221
2017
Q4
$2.36M Buy
72,118
+23,146
+47% +$759K ﹤0.01% 3889
2017
Q3
$1.53M Buy
48,972
+16,308
+50% +$509K ﹤0.01% 4115
2017
Q2
$911K Buy
32,664
+6,793
+26% +$189K ﹤0.01% 4439
2017
Q1
$667K Buy
25,871
+12,976
+101% +$335K ﹤0.01% 4663
2016
Q4
$295K Sell
12,895
-78,370
-86% -$1.79M ﹤0.01% 5192
2016
Q3
$2.38M Buy
91,265
+11,346
+14% +$296K ﹤0.01% 3353
2016
Q2
$1.81M Sell
79,919
-95,193
-54% -$2.15M ﹤0.01% 3508
2016
Q1
$3.84M Buy
175,112
+173,101
+8,608% +$3.79M ﹤0.01% 2769
2015
Q4
$64K Buy
2,011
+680
+51% +$21.6K ﹤0.01% 5620
2015
Q3
$38K Buy
1,331
+115
+9% +$3.28K ﹤0.01% 5833
2015
Q2
$44K Buy
1,216
+215
+21% +$7.78K ﹤0.01% 5901
2015
Q1
$30K Buy
+1,001
New +$30K ﹤0.01% 5954